Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical prognostic factors in advanced epithelioid haemangioendothelioma: a retrospective case series analysis within the Italian Rare Cancers Network.
Frezza AM, Napolitano A, Miceli R, Badalamenti G, Brunello A, Buonomenna C, Casali PG, Caraceni A, Grignani G, Gronchi A, Infante G, Morosi C, Saita L, Simeone N, Zaffaroni N, Vincenzi B, Stacchiotti S. Frezza AM, et al. ESMO Open. 2021 Apr;6(2):100083. doi: 10.1016/j.esmoop.2021.100083. Epub 2021 Mar 10. ESMO Open. 2021. PMID: 33714008 Free PMC article.
Docetaxel induced pericardial effusion.
Vincenzi B, Santini D, Frezza AM, Rocci L, Tonini G. Vincenzi B, et al. Among authors: frezza am. J Exp Clin Cancer Res. 2007 Sep;26(3):417-20. J Exp Clin Cancer Res. 2007. PMID: 17987805
New therapies in soft tissue sarcoma.
Vincenzi B, Frezza AM, Santini D, Tonini G. Vincenzi B, et al. Among authors: frezza am. Expert Opin Emerg Drugs. 2010 Jun;15(2):237-48. doi: 10.1517/14728211003592108. Expert Opin Emerg Drugs. 2010. PMID: 20465449 Review.
PML down-regulation in soft tissue sarcomas.
Vincenzi B, Perrone G, Santini D, Grosso F, Silletta M, Frezza A, Rossi S, Russo A, Rabitti C, Gebbia N, Badalamenti G, Casali P, Muda AO, Dei Tos AP, Tonini G. Vincenzi B, et al. J Cell Physiol. 2010 Sep;224(3):644-8. doi: 10.1002/jcp.22161. J Cell Physiol. 2010. PMID: 20578240
Target therapy in gastrointestinal tract sarcoma: What is new?
Vincenzi B, Frezza AM, Santini D, Tonini G. Vincenzi B, et al. Among authors: frezza am. World J Gastrointest Oncol. 2010 Jan 15;2(1):1-4. doi: 10.4251/wjgo.v2.i1.1. World J Gastrointest Oncol. 2010. PMID: 21160809 Free PMC article.
The role of S-adenosylmethionine in preventing oxaliplatin-induced liver toxicity: a retrospective analysis in metastatic colorectal cancer patients treated with bevacizumab plus oxaliplatin-based regimen.
Vincenzi B, Daniele S, Frezza AM, Berti P, Vespasiani U, Picardi A, Tonini G. Vincenzi B, et al. Among authors: frezza am. Support Care Cancer. 2012 Jan;20(1):135-9. doi: 10.1007/s00520-010-1078-4. Epub 2011 Jan 14. Support Care Cancer. 2012. PMID: 21229271
PML as a potential predictive factor of oxaliplatin/fluoropyrimidine-based first line chemotherapy efficacy in colorectal cancer patients.
Vincenzi B, Santini D, Perrone G, Graziano F, Loupakis F, Schiavon G, Frezza AM, Ruzzo AM, Rizzo S, Crucitti P, Galluzzo S, Zoccoli A, Rabitti C, Muda AO, Russo A, Falcone A, Tonini G. Vincenzi B, et al. Among authors: frezza am. J Cell Physiol. 2012 Mar;227(3):927-33. doi: 10.1002/jcp.22801. J Cell Physiol. 2012. PMID: 21503888
98 results